The SUMO Pathway in Hematomalignancies and Their Response to Therapies
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms20163895
Abstract: SUMO (Small Ubiquitin-related MOdifier) is a post-translational modifier of the ubiquitin family controlling the function and fate of thousands of proteins. SUMOylation is deregulated in various hematological malignancies, where it participates in both tumorigenesis and… read more here.
Keywords: sumoylation; pathway hematomalignancies; response; hematomalignancies response ... See more keywords